Ketamine Completed Phase 1 Trials for Confusion / Schizophrenia / Perceptual Disorders Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01101659Ketamine Challenge Study With JNJ-40411813